Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Coll Surg. 2014 Jun;218(6):1141-1147.e1. doi: 10.1016/j.jamcollsurg.2014.01.053. Epub 2014 Feb 28.

Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries.

Author information

  • 1Center for Outcomes Research Surgical Research Scholars Program, Department of Surgery, University of Massachusetts, Worcester, MA. Electronic address: courtney.collins@umassmemorial.org.
  • 2Center for Outcomes Research Surgical Research Scholars Program, Department of Surgery, University of Massachusetts, Worcester, MA.

Abstract

BACKGROUND:

The incidence of community-acquired Clostridium difficile (CACD) is increasing in the United States. Many CACD infections occur in the elderly, who are predisposed to poor outcomes. We aimed to describe the epidemiology and outcomes of CACD in a nationally representative sample of Medicare beneficiaries.

STUDY DESIGN:

We queried a 5% random sample of Medicare beneficiaries (2009-2011 Part A inpatient and Part D prescription drug claims; n = 864,604) for any hospital admission with a primary ICD-9 diagnosis code for C difficile (008.45). We examined patient sociodemographic and clinical characteristics, preadmission exposure to oral antibiotics, earlier treatment with oral vancomycin or metronidazole, inpatient outcomes (eg, colectomy, ICU stay, length of stay, mortality), and subsequent admissions for C difficile.

RESULTS:

A total of 1,566 (0.18%) patients were admitted with CACD. Of these, 889 (56.8%) received oral antibiotics within 90 days of admission. Few were being treated with oral metronidazole (n = 123 [7.8%]) or vancomycin (n = 13 [0.8%]) at the time of admission. Although 223 (14%) patients required ICU admission, few (n = 15 [1%]) underwent colectomy. Hospital mortality was 9%. Median length of stay among survivors was 5 days (interquartile range 3 to 8 days). One fifth of survivors were readmitted with C difficile, with a median follow-up time of 393 days (interquartile range 129 to 769 days).

CONCLUSIONS:

Nearly half of the Medicare beneficiaries admitted with CACD have no recent antibiotic exposure. High mortality and readmission rates suggest that the burden of C difficile on patients and the health care system will increase as the US population ages. Additional efforts at primary prevention and eradication might be warranted.

Comment in

PMID:
24755188
PMCID:
PMC4412342
DOI:
10.1016/j.jamcollsurg.2014.01.053
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center